News

Dr. Pergam has been quoted in the New York Times, Washington Post, Wall Street Journal, The Atlantic, Bloomberg News, Axios, NBC, USA Today, Cure Magazine, Cancer Today, Scientific American, The Guardian, Geekwire, Self, ESPN, Oprah Magazine, Healio, HemOnc Today, Women’s  Health, King5 News, KUOW, The Seattle Times, for work spanning from pandemic preparedness especially for the immunocompromised during COVID-19, to influenza research and precautions during flu season, to medical marijuana usage among cancer patients. 

Visit our Group Blog for the latest on what we're up to!

2021 | 2020 | 2018 | 2017 | 20162015 | 2014

2021

Who really needs coronavirus herd immunity? People with weakened immune systems

The Seattle Times | June 1, 2021

COVID-19 precautions shut down flu this season, but what will next winter bring?

The Seattle Times | March 14, 2021

Minorities Are Underrepresented in Vaccine Clinical Trials

Contagion Live | February 25, 2021

Vaccine trials fail to capture representative sample of Americans

Axios | February 21, 2021

Racial diversity lags in clinical vaccine trials despite push for inclusion, JAMA study finds

NBC | February 19, 2021 

‘A massive gap in information’: Most vaccine clinical trials fail to report data on participants’ ethnicity or race

Stat News | February 19, 2021

Community engagement in HIV trials guides equity for COVID-19 vaccine studies

Hutch News | February 19, 2021

COVID-19 vaccination for people with cancer, with Steven Pergam, MD, MPH

Living Beyond Breast Cancer | February 19, 2021

Coronavirus Vaccines and People with Cancer: A Q&A with Dr. Steven Pergam

National Cancer Institute | February 10, 2021

Oncologists can allay COVID-19 vaccination concerns of patients with cancer, survivors

Healio | February 8, 2021

With COVID-19 vaccine in short supply, confusion abounds over second shot

The Seattle Times | February 5, 2021

Tip Sheet: COVID-19 vaccines, SARS-CoV-2 mutations, shedding pandemic pounds – and nematode nerve cells -- Summaries of recent Fred Hutch research findings and other news

Hutch News | February 4, 2021

In the Vaccine Scramble, Cancer Patients Are Left Behind 

The New York Times | February 3, 2021

NCCN shares guidance for vaccinating cancer patients against COVID-19

The Cancer Letter | January 29, 2021

Cancer patients and the COVID-19 vaccines: Clinicians, cancer patients and coronavirus researchers weigh in on vaccination safety, timing, allergy concerns and more

Hutch News | January 14, 2021

Medical Marijuana & Cancer: What you Need to Know

The Bloodline with LLS: A Podcast For Patients and Caregivers | January 11, 2021

2020

Cancer clinics confident in COVID-19 precautions to protect patients, survivors

Healio/HemOnc Today | December 23, 2020

What to expect as Moderna’s coronavirus vaccine rolls out in Washington state

The Seattle Times | December 18, 2020

FDA plans to authorize Moderna's coronavirus vaccine quickly

CNN | December 17, 2020

Moderna’s COVID-19 vaccine gets panel support, set to become the second cleared by FDA for use in US

USA Today | December 17, 2020

FDA plans to OK 2nd COVID-19 vaccine after panel endorsement

AP News | December 17, 2020

Recommendation paves way for FDA authorization of Moderna Covid vaccine in US

The Guardian | December 17, 2020

COVID complicates Thanksgiving as families struggle to modify 2020 holiday plans

CNBC | November 12, 2020

Almost no flu yet, but still -- get your shot: COVID-19 pandemic makes prevention measures against influenza all the more important

Hutch News | October 30, 2020

 

2019

2018

Dr. Steve Pergam receives Dr. Ali Al-Johani Award

Hutch News | Mary Engel | Feb. 7, 2018
The Dr. Ali Al-Johani Award recognizes exceptional medical care and compassion to transplant patients and families

Flu season tips for cancer patients

Hutch News | Mary Engel | Feb. 6, 2018
Dr. Steve Pergam and other Fred Hutch infectious disease specialists offer tips on how immunocompromised patients can protect themselves from the flu, and to do if they get sick

When bad bugs jump from farm to bedside

Hutch News | Mary Engel | Jan. 26, 2018
‘Big Chicken’ author, infectious disease researchers take aim at antibiotic resistance driven by agriculture, medicine

Science to watch in 2018: From immunotherapy to gene therapy, big data to new tech

Hutch News | Rachel Tompa | Jan. 12, 2018
Fred Hutch experts lend their predictions for the coming year’s advances

2017

What we can learn about global flu evolution from individual infections

Hutch News | Rachel Tompa | June 27, 2017
Study of 10-year-old flu samples finds virus’s evolution in individual transplant patients partially mirrors later global trends

Good News at Fred Hutch

Hutch News | Jan. 19, 2017
Researchers from Fred Hutch's Infectious Disease Sciences Program and the University of Washington's Virology Divison gathered for a symposium to discuss a broad variety of infectious disease-related topics.

2016

Medical myth busting: Separating fact from fiction about colds and flu

Hutch News | Mary Engel | Nov. 16, 2016
We ask an infection prevention expert to bust myths and offer tips on staying healthy during cold and flu season

Researchers who tweet: Spreading science 140 characters at a time

Hutch News | Mary Engel | March 11, 2016
3 Fred Hutch researchers talk about getting #science out into the world, 140 characters at a time

Researching your cancer online: dive in or steer clear?

Hutch News | Bill Briggs | Feb. 10, 2016
Some patients feel control over disease by scouring Web; others stoke hope by staying off Internet

After chemotherapy, immune system recovery may be slower than believed

Hutch News | Diane Mapes | Jan. 26, 2016
Chemo weakens the immune system for up to nine months, especially in smokers, one study finds

2015

Cannabis and cancer: Medical marijuana gains favor among some patients despite safety concerns

Hutch News | Bill Briggs | July 17, 2015
But some doctors voice concerns about safety, risks of Rx weed

For flu shot compliance, stick beats carrot

Science Spotlight | April 20, 2015
Fred Hutch questions examine the question: how can influenza vaccination rates be maximized at an institution where the baseline compliance already is high?

When the doctor is the patient

Hutch News | Mary Engel | March 23, 2015
A kidney transplant and a cancer diagnosis helped shape the career of infection-control expert Steve Pergam

Nailing down the debate on antibiotic resistance in post-transplant patients

Science Spotlight | Feb. 15, 2015
Fred Hutch researchers examine the incidence of antibiotic resistence and mortality rates of hematopoietic cell transplant recipients. 

Protecting the most vulnerable from measles

Nutch News | Joely Johnson Mork | Feb. 6, 2015
What a growing measles outbreak means for those with cancer and others who can’t get the vaccine

2014

Flu shot strategy sends health worker jabs soaring at SCCA

Hutch News | JoNel Aleccia | Sept. 23, 2014
Participation climbs to 97 percent, protects vulnerable patients, Fred Hutch infection expert says